You're currently on:

Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant Infections

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant Infections

Availability: In stock.

$20.00
Add Items to Cart
Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant Infections

Description

Leveraging Novel and Existing Pathways to Approve New Therapeutics to Treat Serious Drug-Resistant Infections

Additional Information

Author Thomas J. Hwang & Aaron S. Kesselheim
Number 2 & 3
Volume 42
Publication AJLM
Journal Year 2016
 

My Cart

You have no items in your shopping cart.